Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gullan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Neuro-Oncology Advances|June 16, 2021
5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patientsAsfand Baig Mirza, Ioannis Christodoulides, Jose Pedro Lavrador, et al.
Acta Neurochirurgica|July 13, 2022
Prognostic factors for surgically managed intramedullary spinal cord tumours: a single-centre case seriesAsfand Baig Mirza, Axumawi Gebreyohanes, James Knight, et al.
Neurosurgery|March 21, 2024
Transcranial Magnetic Stimulation-Based Machine Learning Prediction of Tumor Grading in Motor-Eloquent GliomasJosé Pedro Lavrador, Ana Mirallave-Pescador, Christos Soumpasis, et al.
Biomedicines|January 8, 2025
In Situ Light-Source Delivery During 5-Aminulevulinic Acid-Guided High-Grade Glioma Resection: Spatial, Functional and Oncological Informed SurgeryJosé Pedro Lavrador, Francesco Marchi, Ali Elhag, et al.
British Journal of Neurosurgery|December 27, 2014
Active dendritic cell immunotherapy for glioblastoma: Current status and challengesStavros Polyzoidis, Juel Tuazon, Lucy Brazil, et al.
Neuro-Oncology|October 26, 2013
Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastomaRoss C Laxton, Sergey Popov, Lawrence Doey, et al.
Frontiers in Neurology|September 5, 2025
Dexamethasone in brain tumor patients: a real-world pharmacovigilance auditVindhya Prasad, Ali Elhag, Louis Onyiriuka, et al.
Acta Neurochirurgica|March 17, 2023
H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case seriesJosé Pedro Lavrador, Zita Reisz, Naomi Sibtain, et al.
Frontiers in Neurology|March 29, 2021
Middle Frontal Gyrus and Area 55b: Perioperative Mapping and Language OutcomesSally Rosario Hazem, Mariam Awan, Jose Pedro Lavrador, et al.
Operative Neurosurgery (Hagerstown, Md.)|February 11, 2022
5-Aminolevulinic Acid-Guided Resection in Grade III Tumors-A Comparative Cohort StudyAsfand Baig Mirza, Jose Pedro Lavrador, Ioannis Christodoulides, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Neuro-Oncology Advances|June 16, 2021
5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patientsAsfand Baig Mirza, Ioannis Christodoulides, Jose Pedro Lavrador, et al.
Acta Neurochirurgica|July 13, 2022
Prognostic factors for surgically managed intramedullary spinal cord tumours: a single-centre case seriesAsfand Baig Mirza, Axumawi Gebreyohanes, James Knight, et al.
Neurosurgery|March 21, 2024
Transcranial Magnetic Stimulation-Based Machine Learning Prediction of Tumor Grading in Motor-Eloquent GliomasJosé Pedro Lavrador, Ana Mirallave-Pescador, Christos Soumpasis, et al.
Biomedicines|January 8, 2025
In Situ Light-Source Delivery During 5-Aminulevulinic Acid-Guided High-Grade Glioma Resection: Spatial, Functional and Oncological Informed SurgeryJosé Pedro Lavrador, Francesco Marchi, Ali Elhag, et al.
British Journal of Neurosurgery|December 27, 2014
Active dendritic cell immunotherapy for glioblastoma: Current status and challengesStavros Polyzoidis, Juel Tuazon, Lucy Brazil, et al.
Neuro-Oncology|October 26, 2013
Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastomaRoss C Laxton, Sergey Popov, Lawrence Doey, et al.
Frontiers in Neurology|September 5, 2025
Dexamethasone in brain tumor patients: a real-world pharmacovigilance auditVindhya Prasad, Ali Elhag, Louis Onyiriuka, et al.
Acta Neurochirurgica|March 17, 2023
H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case seriesJosé Pedro Lavrador, Zita Reisz, Naomi Sibtain, et al.
Frontiers in Neurology|March 29, 2021
Middle Frontal Gyrus and Area 55b: Perioperative Mapping and Language OutcomesSally Rosario Hazem, Mariam Awan, Jose Pedro Lavrador, et al.
Operative Neurosurgery (Hagerstown, Md.)|February 11, 2022
5-Aminolevulinic Acid-Guided Resection in Grade III Tumors-A Comparative Cohort StudyAsfand Baig Mirza, Jose Pedro Lavrador, Ioannis Christodoulides, et al.
Pageof 8